Nassau University Medical Center is a public teaching hospital affiliated with the Health Sciences Center of Stony Brook University and with Northwell Health. The 19 story, 631 bed Level I Trauma Center is located at 2201 Hempstead Turnpike, East Meadow, NY.

There are 631 beds in Nassau University Medical Center.

During the past decade, Nassau University Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nassau University Medical Center" #1 sponsor was "Northwell Health" with 3 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Pharmacia" with 2 trials sponsored and "Castle Creek Biosciences, LLC." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nassau University Medical Center" #1 collaborator was "Nassau University Medical Center" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Hoechst Marion Roussel" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Jacobi Medical Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Nassau University Medical Center" are "HIV Infections" (7 trials), "Asthma" (1 trials), "Chronic Heart Failure" (1 trials), "Critically Ill" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Nassau University Medical Center" in a lesser frequency.

Most popular intervention types in "Nassau University Medical Center" are "Drug" (10 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (2 trials), "Placebo" (2 trials), "Rifabutin" (2 trials), "Zidovudine" (2 trials) and "Autologous Human Fibroblasts (Isolagen TherapyTM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nassau University Medical Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Nassau University Medical Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Nassau University Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nassau University Medical Center, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".